16 related articles for article (PubMed ID: 2346304)
1. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1985; 5(5):471-7. PubMed ID: 4062251
[TBL] [Abstract][Full Text] [Related]
2. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
Hansson J; Edgren M; Ehrsson H; Lewensohn R; Ringborg U
Anticancer Res; 1987; 7(1):97-104. PubMed ID: 3566189
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
Parsons PG; Carter FB; Morrison L; Regius Mary Sister
Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U
Anticancer Res; 1991; 11(5):1725-30. PubMed ID: 1768043
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-mercapto-2'-deoxyuridine on the incorporation of nucleosides into RNA and DNA in a primary lymphocyte culture system.
Bogyo D; Bardos TJ; Chmielewicz ZF
Cancer Res; 1976 Sep; 36(9 pt.1):3284-93. PubMed ID: 975090
[TBL] [Abstract][Full Text] [Related]
6. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
Ringborg U; Hansson J; Jungnelius U; Lewensohn R; Skog S
Anticancer Res; 1990; 10(2A):297-301. PubMed ID: 2346304
[TBL] [Abstract][Full Text] [Related]
7. [Early changes in the chromatin of mitogen-stimulated lymphocytes (a review of the literature)].
Staĭkova MA
Eksp Med Morfol; 1975; 14(2):61-5. PubMed ID: 770140
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
